However, in contrast, ELK3 over-expression inhibited the cell cycle progression of pancreatic carcinoma cells, resulting in an increase in G0/G1 phase fraction and a decrease in S phase fraction [34]. The gene discussed is ELK3; the disease is exocrine pancreatic carcinoma.